Simon Leboube
@sleboube
Followers
38
Following
21
Media
0
Statuses
16
Cardiologist @CHUdeLyon PhD student in IRIS Team @CarMeN_lab_lyon
Lyon
Joined June 2011
RT @BochatonThomas: Glad to be back at #aha2022 in Chicago with my colleagues @sleboube @PaillardMel @GomezLudovik @CHUdeLyon @HCL_researc….
0
4
0
RT @LDLCASVEL: 🙏 Dans le cadre des Journées de l’Avenir organisées dans tous les clubs de LNB, Gaëtan Muller, Alain Béral, Président de la….
0
5
0
RT @LaboratoryIris: Félicitations au Professeur Marco Vola du GHE cardiologie des Hospices Civils de Lyon pour l’obtention de son projets R….
0
4
0
RT @BaetzDelphine: les Journées de l'Avenir !. L'équipe Lyonnaise @LaboratoryIris a été sélectionnée pour ses recherches dans le domaine ca….
0
2
0
RT @AhmadHayek0: From @jaccjournals Check our latest article! @BochatonThomas @mewton_nathan @CHUdeLyon @alexPaccal….
0
3
0
RT @BochatonThomas: Our latest article: Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era o….
pubmed.ncbi.nlm.nih.gov
The study highlights that sST2 levels at 24 h are associated with an increased risk to adverse clinical events in both diseases.
0
4
0
RT @LaboratoryIris: After his excellent thesis defense, Alexandre Paccalet is now in Nahrendorf laboratory (Harvard University, Boston) for….
0
4
0
RT @BochatonThomas: Serum soluble Tumor Necrosis Factor Receptor (sTNFR) 1 and 2 are early prognosis markers after STEMI .
www.frontiersin.org
Background: Inflammation following STEMI playing dual role, beneficial and deleterious, there is a need to find new biomarkers of STEMI severity.Objective: W...
0
5
0
RT @AhmadHayek0: Transcatheter mitral valve repair to treat postmyocardial infarction papillary muscle rupture Hayek A, Grinberg D, Derimay….
0
3
0
RT @AhmadHayek0: Acute pulmonary embolism and thrombus entrapped in the patent foramen ovale in a patient with COVID-19 Hayek A, Flagiello….
0
2
0
RT @LaboratoryIris: 📣Great news for our PhD student @alexPaccalet, who recently got supported by @Servier Institute for his post-doctoral p….
0
4
0
Soluble C-Met is a biomarker of clinical outcomes after STEMI.From @jaccjournals .@BochatonThomas @alexPaccalet @crola_da @mewton_nathan @CHUdeLyon @LaboratoryIris @fedecardio @AngoulvantD.
0
0
3
RT @LaboratoryIris: Our Phd student have something to say about myocardial ischemia-reperfusion injury and diabetes!! !! 🫀💊 .
0
4
0
RT @BochatonThomas: Our last article: .Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patien….
0
3
0
RT @alexPaccalet: Hey #cardiotwitter 📣 RIFIFI study is out 📣. Myocardial hemorrhage present a strongest relationship with inflammatory biom….
0
3
0
RT @alexPaccalet: Hsp-70 as a biomarker of Clinical outcomes after STEMI. @JACCJournals @BochatonThomas @ovizem @CHUdeLyon @mewton_nathan….
0
4
0